Mira Pharmaceuticals (MIRA) Prepaid Assets (2023 - 2025)
Mira Pharmaceuticals (MIRA) posted Prepaid Assets of $28146.0 for Q4 2025, down 54.56% sequentially from $61936.0 in Q3 2025, and down 18.31% YoY from $34454.0 in Q4 2024.
Mira Pharmaceuticals (MIRA) Prepaid Assets (2023 - 2025) Analysis & Trends
Mira Pharmaceuticals (MIRA) has 3 years of Prepaid Assets data on file, last reported at $28146.0 in Q4 2025.
- Quarterly Prepaid Assets fell 18.31% year-over-year to $28146.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $28146.0 (down 18.31% YoY) and the FY2025 annual result came in at $28146.0, down 18.31% from the prior year.
- Prepaid Assets retreated to $28146.0 in Q4 2025 per MIRA's latest filing, from $61936.0 in the prior quarter.
- The five-year high for Prepaid Assets was $254293.0 in Q3 2023, with the low at $13958.0 in Q2 2023.
- Average Prepaid Assets over 3 years is $116951.5, with a median of $94488.0 recorded in 2024.
- Year-over-year, Prepaid Assets tumbled 85.87% in 2024 and fell 14.42% in 2025.
- Mira Pharmaceuticals' Prepaid Assets stood at $243802.0 in 2023, then plunged by 85.87% to $34454.0 in 2024, then dropped by 18.31% to $28146.0 in 2025.
- Business Quant data shows MIRA's Prepaid Assets at $28146.0 in Q4 2025, $61936.0 in Q3 2025, and $102404.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - |
| 10 | Mira Pharmaceuticals | 22.51 Mn | 11.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 28,146.00 |
| Sep 30, 2025 | 61,936.00 |
| Jun 30, 2025 | 102,404.00 |
| Mar 31, 2025 | 158,614.00 |
| Dec 31, 2024 | 34,454.00 |
| Sep 30, 2024 | 86,572.00 |
| Mar 31, 2024 | 185,336.00 |
| Dec 31, 2023 | 243,802.00 |
| Sep 30, 2023 | 254,293.00 |
| Jun 30, 2023 | 13,958.00 |